Short answer: When a biopsy of a lymph node shows cancer cells that have spread from somewhere else, but routine tests have not found where they started, doctors call it a cancer (or carcinoma) of unknown primary. An FDG PET-CT scan is commonly used next, because it scans most of the body in one go and can point to the likely starting site and show where else the disease is. It does not always find the primary, and a cancer of unknown primary can still be treated when no primary is found.
Hearing “it is cancer, but we do not know where it came from” is one of the most unsettling things a family can be told. It sounds as if something has been missed. Usually nothing has. This page explains what the phrase means, why the PET-CT has been asked for, what it can and cannot tell you, and what normally happens after it.
What “cancer of unknown primary” actually means
Every cancer starts in one organ. That starting point is called the primary. Sometimes cells break away and settle somewhere else, most often in a lymph node (a small bean-shaped gland that filters fluid from nearby tissues). A deposit that has travelled like this is called a metastasis, or secondary.
Under the microscope, the cells in a metastasis usually keep the features of where they came from. So a lymph node biopsy often says “metastatic carcinoma”, and further stains on the sample (called immunohistochemistry, or IHC) give clues about the likely origin.
Doctors use the term cancer of unknown primary (CUP) when the secondary has been confirmed but the examination, blood tests, biopsy findings and first scans have not shown where it started. It is a working label for a stage of the investigation, and it often changes once more tests are done.
Why the primary can be hard to find
- The primary may be very small, smaller than a routine CT can show clearly
- It may be hidden in an area that is hard to see, such as the back of the throat or tongue, or deep in the abdomen
- In some cases the original tumour seems to stay tiny, or even shrink, while the secondary keeps growing
- In some people, the primary is never found at all, even after every test
Why doctors order an FDG PET-CT
FDG is a form of glucose with a small radioactive label. Many cancers use glucose faster than normal tissue, so they collect more FDG and appear bright on the PET images. The CT part of the scan shows the anatomy, so each bright area can be placed exactly.
For a cancer of unknown primary, this is useful for three reasons:
- It looks at most of the body in one test. A whole-body study usually covers from the skull base to the mid-thighs, instead of one region at a time.
- It can show a small active area that looked normal on CT. A primary that is too small to stand out by size alone may still stand out by its activity.
- It maps where else the disease is. Your oncologist needs to know whether the cancer is in one area or several, because that shapes treatment, even if the primary is never found.
It also helps with the next step. If the PET-CT shows several abnormal areas, it can show which one is easiest and safest to biopsy.
A note for cancer found in a neck node
When the affected lymph node is in the neck, the hidden primary is often somewhere in the mouth, throat or voice box. In this situation, doctors often prefer that the PET-CT is done before any examination under anaesthesia or biopsies of the throat, because those procedures cause temporary inflammation that also shows up on the scan. If your ENT or oncology team has asked for the scan in a particular order, that is usually the reason. Follow their plan.
What the PET-CT cannot do
It is important to go in with honest expectations.
- It does not always find the primary. Published studies report that FDG PET-CT points to the likely primary in a portion of patients, often somewhere between a quarter and a half.
- A bright spot is not automatically cancer. Infection, tuberculosis (a common cause of enlarged lymph nodes in India), inflammation, healing tissue and some benign growths also take up FDG. A suspicious area usually needs a biopsy to confirm what it is.
- Some cancers take up very little FDG. Very small tumours and some slow-growing types can be quiet on the scan.
- It is not a diagnosis by itself. The report describes what is seen. Your treating doctor puts it together with the biopsy, stains, blood tests and examination.
If the biopsy stains suggest a neuroendocrine tumour (a type that grows from hormone-producing cells), your doctor may ask for a different scan, such as a 68Ga DOTANOC PET-CT, because many of those tumours show up better with that tracer than with FDG.
What happens after the scan
The next steps depend on what the scan shows, and your oncologist will guide them. Broadly, there are three possibilities.
The scan points to a likely primary
Your doctor will usually want a biopsy from that area, or a focused test such as an endoscopy, to confirm it. Once confirmed, the cancer is treated according to where it started.
The scan shows more spread but no clear primary
This still helps. It tells your team the extent of the disease and which site can be biopsied most easily if more tissue is needed for further stains or genetic tests.
The scan shows nothing beyond what is already known
That is useful information too. It suggests the disease may be limited to the area already found, which can open up treatment aimed at that area.
In all three cases, treatment does not have to wait for the primary to be found. Oncologists treat cancers of unknown primary based on the type of cells, the stains, where the disease is, and the patient’s overall health. Many patients are treated without the primary ever being identified.
If a biopsy is needed
Neurad also performs CT- and ultrasound-guided biopsy and FNAC (fine needle aspiration cytology). Samples are sent to an accredited outside laboratory for examination. Neurad is a diagnostic centre: treatment is planned and given by your oncologist. For the difference between the two sampling methods, see FNAC vs biopsy.
Looking after yourself while you wait
The weeks of tests after a CUP diagnosis are often harder than the diagnosis itself, because there is so much uncertainty. A few things help many families:
- Remember that “unknown” describes the investigation, not your outlook. It means the starting point has not been found yet. It does not mean your doctors do not know what to do.
- Keep one folder for everything. Biopsy reports, stain results, scan CDs and blood tests. Each new doctor will ask for them.
- Write your questions down before each appointment, and take someone with you to listen and take notes.
- Avoid reading survival figures online. CUP covers many very different situations, and general numbers say little about one person.
- It is fine to ask for a second opinion. Good oncologists expect it.
- Look after the basics. Eating, sleep and some daily walking all matter, and the patient will feel the difference.
What to do next
- Ask your oncologist exactly which PET-CT they want (usually an FDG whole-body study), and whether any extra area needs to be covered.
- Collect the biopsy report, the stain (IHC) report and all earlier scans on CD or film.
- Send the prescription on WhatsApp. An FDG whole-body PET-CT at Neurad is Rs 7,999*, all-inclusive of scan, tracer and reporting.
- Follow the fasting instructions you are given, and tell us if the patient is diabetic or on steroids.
- Take the report back to the doctor who ordered it. They will decide the next step.
*Rates as on date. The final all-inclusive rate is confirmed with you before booking.
Frequently asked questions
The biopsy says metastatic carcinoma in a lymph node. Does that mean the cancer is everywhere?
Not necessarily. It means the cancer has reached at least that node. A PET-CT is one of the tests that shows whether it is limited to one area or has spread further, and that is exactly why it is ordered.
Will a PET scan definitely find where my cancer started?
No. It finds the likely primary in some patients but not all. Even when it does not, it shows the extent of the disease, which your doctor needs for planning treatment.
If the PET-CT finds nothing new, has it been wasted?
No. Knowing that there is no other active disease is important information. It can make treatment directed at the known area a realistic option.
Can cancer of unknown primary be treated if the primary is never found?
Yes. Oncologists plan treatment using the cell type, the stain results, where the disease is and the patient’s health. Many patients are treated without the primary being identified.
Why does my doctor want the PET-CT before the throat biopsies?
For cancer in a neck node, biopsies and examination under anaesthesia cause temporary inflammation that can show up on the scan and be confused with disease. Doing the PET-CT first gives a cleaner picture and can show the surgeon where to look.
Can a lymph node light up on PET because of TB rather than cancer?
Yes. Tuberculosis and other infections can make lymph nodes very bright on an FDG scan. That is why the report is always read with the biopsy results, and why a new bright area often needs sampling.
Send the prescription and reports
Send your prescription on WhatsApp to 8368225620, along with the biopsy report if you have it. We will confirm the study your doctor has asked for, the preparation and the all-inclusive rate in writing before you book. You can also call 8368225620 or 7011968879, Monday to Saturday, 8 AM to 5 PM. Neurad is near Paschim Vihar West Metro Station, New Delhi.
Written by the Neurad patient information team. PET-CT scans at Neurad are reported by DNB nuclear medicine physicians Dr. Swagat Dash and Dr. Pradeep Chaurasiya. This article is general information and does not replace advice from your own doctor.
Related reading
- Can a PET scan detect cancer? What it shows and what it misses
- FNAC vs biopsy: which sample your doctor needs, and why
- CT-guided FNAC and biopsy: what the procedure involves
- FDG vs PSMA vs FAPI vs DOTANOC: which tracer for which question
- PET-CT scan at Neurad: every study we offer, with rates
This page is general information about cancer of unknown primary and the role of PET-CT. It is not medical advice and must not be used to interpret your own report or decide on treatment. Those decisions belong to your treating oncologist, who reads every scan alongside your biopsy, examination and other tests.
